Back to Journals » Vascular Health and Risk Management » Volume 10

Defining risks and predicting adverse events after lower extremity bypass for critical limb ischemia

Authors Siracuse J, Huang Z, Gill H, Parrack I, Schneider D, Connolly P, Meltzer A

Received 29 March 2014

Accepted for publication 28 April 2014

Published 23 June 2014 Volume 2014:10 Pages 367—374

DOI https://doi.org/10.2147/VHRM.S54350

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2


Jeffrey J Siracuse, Zhen S Huang, Heather L Gill, Inkyong Parrack, Darren B Schneider, Peter H Connolly, Andrew J Meltzer

Division of Vascular and Endovascular Surgery, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA

Abstract: Successful treatment of patients with critical limb ischemia (CLI), hinges on the adequacy of revascularization. However, CLI is associated with a severe burden of systemic atherosclerosis, and patients often suffer from multiple cardiovascular comorbidities. Therefore, CLI patients in general represent a cohort at increased risk for procedural complications and adverse events. Although endovascular therapy represents a minimally invasive alternative to open surgical bypass, the durability of surgical reconstruction is superior, and it remains the “gold standard” approach to revascularization in CLI. Therefore, selection of the optimal treatment modality for individual patients requires careful consideration of the procedural risks and likelihood of adverse events associated with surgery. Individualized decision-making with regard to revascularization strategy requires a comprehensive understanding of the likelihood of adverse outcomes after major surgery. Here we review the risks of surgical bypass in patients with CLI, with particular emphasis on the identification of preoperative variables that predict poor outcome.

Keywords: critical limb ischemia, bypass, adverse events

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]